BioSpace

Verdicts for Summit/Akeso, Capricor, Vertex mark FDA’s stacked November

Also lined up are target action dates for Sanofi’s Gaucher disease therapy, GSK’s lung cancer medicine and BridgeBio’s muscular dystrophy drug.

By BioSpace

1 min read
Verdicts for Summit/Akeso, Capricor, Vertex mark FDA’s stacked November
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights